Genetic Signatures Limited (GSS.AX)

AUD 0.38

(-7.41%)

Operating Expenses Summary of Genetic Signatures Limited

Genetic Signatures Limited's latest annual operating expenses in 2024 was 4.3 Million AUD , down -29.97% from previous year.
Genetic Signatures Limited's latest quarterly operating expenses in 2024 FY was 6.01 Million AUD , down -2.21% from previous quarter.
Genetic Signatures Limited reported a annual operating expenses of 6.15 Million AUD in annual operating expenses 2023, up 44.92% from previous year.
Genetic Signatures Limited reported a annual operating expenses of 4.24 Million AUD in annual operating expenses 2022, up 56.47% from previous year.
Genetic Signatures Limited reported a quarterly operating expenses of 2.64 Million AUD for 2024 Q2, down 0.0% from previous quarter.
Genetic Signatures Limited reported a quarterly operating expenses of 3.15 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Genetic Signatures Limited (2024 - 2013)

Historical Annual Operating Expenses of Genetic Signatures Limited (2024 - 2013)

Year	Operating Expenses	Operating Expenses Growth
2024	4.3 Million AUD	-29.97%
2023	6.15 Million AUD	44.92%
2022	4.24 Million AUD	56.47%
2021	2.71 Million AUD	10.06%
2020	2.46 Million AUD	-68.49%
2019	7.82 Million AUD	20.46%
2018	6.49 Million AUD	23.47%
2017	5.25 Million AUD	-2.0%
2016	5.36 Million AUD	42.94%
2015	3.75 Million AUD	75.41%
2014	2.14 Million AUD	1.5%
2013	2.1 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 FY	6.01 Million AUD	-2.21%
2024 Q2	2.64 Million AUD	0.0%
2024 Q4	3.15 Million AUD	0.0%
2023 Q4	3.37 Million AUD	0.0%
2023 FY	6.15 Million AUD	44.92%
2023 Q2	2.9 Million AUD	0.0%
2022 Q4	2.06 Million AUD	0.0%
2022 FY	4.24 Million AUD	56.47%
2022 Q2	2.2 Million AUD	0.0%
2021 FY	2.71 Million AUD	10.06%
2021 Q4	1.32 Million AUD	0.0%
2021 Q2	1.47 Million AUD	0.0%
2020 Q2	1.11 Million AUD	0.0%
2020 FY	2.46 Million AUD	-68.49%
2020 Q4	1.48 Million AUD	0.0%
2019 Q4	1.1 Million AUD	0.0%
2019 Q2	3.76 Million AUD	0.0%
2019 FY	7.82 Million AUD	20.46%
2018 Q4	3.31 Million AUD	0.0%
2018 Q2	3.18 Million AUD	0.0%
2018 FY	6.49 Million AUD	23.47%
2017 Q2	2.54 Million AUD	0.0%
2017 FY	5.25 Million AUD	-2.0%
2017 Q4	2.71 Million AUD	0.0%
2016 Q2	2.56 Million AUD	0.0%
2016 Q4	2.8 Million AUD	0.0%
2016 FY	5.36 Million AUD	42.94%
2015 Q2	1.95 Million AUD	0.0%
2015 Q4	2.01 Million AUD	584.4%
2015 FY	3.75 Million AUD	75.41%
2015 Q3	294.16 Thousand AUD	-84.94%
2015 Q1	- AUD	0.0%
2014 FY	2.14 Million AUD	1.5%
2014 Q2	- AUD	0.0%
2014 Q3	- AUD	0.0%
2014 Q4	- AUD	0.0%
2013 FY	2.1 Million AUD	0.0%

Peer Operating Expenses Comparison of Genetic Signatures Limited

Name	Operating Expenses	Operating Expenses Difference
Australian Clinical Labs Limited	81.54 Million AUD	94.717%
BCAL Diagnostics Limited	8.54 Million AUD	49.586%
Genetic Technologies Limited	3.9 Million AUD	-10.335%
Healius Limited	265.1 Million AUD	98.375%
Imagion Biosystems Limited	15.53 Million AUD	72.268%
Integral Diagnostics Limited	61.88 Million AUD	93.039%
INOVIQ Ltd	6.8 Million AUD	36.71%
Microba Life Sciences Limited	5.9 Million AUD	27.05%
Monash IVF Group Limited	91.1 Million AUD	95.272%
Rhythm Biosciences Limited	5.34 Million AUD	19.475%
Sonic Healthcare Limited	1.49 Billion AUD	99.712%